Callan Family Office, LLC Takeda Pharmaceutical CO LTD Transaction History
Callan Family Office, LLC
- $1.57 Trillion
- Q4 2024
A detailed history of Callan Family Office, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Callan Family Office, LLC holds 19,924 shares of TAK stock, worth $269,571. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,924Holding current value
$269,571% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding TAK
# of Institutions
333Shares Held
73.3MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$72.5 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$62.7 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$61.7 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$46.1 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...